Picture of Clean Power Hydrogen logo

CPH2 — Clean Power Hydrogen News Story

0.000.00%
gb flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro CapSucker Stock

Clean Power Hydrogen - Memorandum of Understanding with Siemens

RNS Number : 7799X

Clean Power Hydrogen PLC

24 March 2026

 

 

24 March 2026

Clean Power Hydrogen plc

("CPH2" or the "Company")

 

Memorandum of Understanding with Siemens plc

 

CPH2 (AIM:CPH2), which has developed market disrupting and IP-protected Membrane-Free Electrolyser ("MFE") technology for the production of commercial high purity hydrogen and above medical-grade purity oxygen, announces that it has entered into a non-binding Memorandum of Understanding ("MOU") with Siemens plc. It is the intention of Siemens and CPH2 to conclude a legally binding agreement in relation to Siemens assisting CPH2 across a range of activities focussed on successfully scaling up CPH2's MFE production and maintaining its technology leadership.

 

Further updates in respect of the progress towards a legally binding agreement between the parties will follow in due course.

 

Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "Our discussions with Siemens cover a range of activities from enhanced process and automation to customer introduction, marketing, 24/7 technical support, training, joint product and process development and Go-to-Market strategies, all with the objective to upscale CPH2 production. We look forward to updating the Market further on this in due course."

 

ENDS

 

Enquiries:

 

Clean Power Hydrogen
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
via Square1 Consulting
Cavendish Capital Markets Limited - NOMAD & Joint Broker
Neil McDonald
Peter Lynch
+44 131 220 9771
+44 131 220 9772
Turner Pope Investments (TPI) Limited - Joint Broker
Andy Thacker/Guy McDougall
+44 203 657 0050
Square1 Consulting Limited
David Bick
+44 7831 381201
  Background on CPH2 CPH2 is the holding company of Clean Power Hydrogen Group Limited which has a decade of dedicated research and product development experience that has delivered global patents in breakthrough hydrogen and oxygen production technology. The Group's strategic objective is to deliver the lowest lifetime Levelised Cost of Hydrogen ("LCOH") in the market in relation to the production of hydrogen at this scale. CPH2 is listed on the AIM market and trades under the ticker LSE: CPH2.   For more information: https://www.cph2.com This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     AGRJJMBTMTATTJF

Recent news on Clean Power Hydrogen

See all news